Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
Go back to Telix and RefleXion Expand Partnership for Prostate Cancer Treatment| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.81 +0.52 (4.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.29 | 52 Week High | $2.18 | |||
| Open | $12.20 | 52 Week Low | $0.30 | |||
| Day High | $12.23 | P/E | N/A | |||
| Day Low | $11.67 | EPS | $-3.32 | |||
| Volume | 215,274 | |||||
